Product
Omega-3
Aliases
fish oil
Name
Omegaven
INN Name
Fish oil
FDA Approved
Yes
3 clinical trials
1 organization
7 indications
1 document
Indication
COVID-19Indication
Diabetes MellitusIndication
Type 1Indication
HypoglycemiaIndication
DiabetesIndication
AutoimmuneIndication
Type 2 DiabetesClinical trial
Feasibility Pilot Clinical Trial of Omega-3 (EPA+DHA) Supplement vs. Placebo for Post-Acute Sequelae of Coronavirus-19 (COVID-19) Recovery Among Health Care WorkersStatus: Terminated, Estimated PCD: 2023-04-21
Clinical trial
A Pilot, Safety and Feasibility Trial of High-Dose Omega-3 Fatty Acids and High-Dose Cholecalciferol (Vitamin D) Supplementation in Type 1 DiabetesStatus: Active (not recruiting), Estimated PCD: 2025-09-01
Clinical trial
Diabetes Prevention in the Vitamin D and Omega-3 TrialStatus: Active (not recruiting), Estimated PCD: 2024-05-30
Document
DailyMed Label: Omegaven
Organization
Fresenius Kabi USA, LLC